NCT04804995CompletedNot Applicable
Headache in Ramadan.
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Danish Headache Center
- Enrollment
- 134
- Locations
- 1
- Primary Endpoint
- Headache frequency
Study Overview
Brief Summary
Headaches are more common in the month of Ramadan in patients who already suffer from migraine. The object of the present study is investigate the frequency in the Ramadan month .
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •age 18-60 years.
- •expectation of fasting for at least 21 of 30 days during the month of Ramadan.
- •understand and answer the questionnaire sent out in Danish.
Exclusion Criteria
- •non-compliance with the headache calendar (defined as non-registration of at least 21 days per 30 days).
Outcomes
Primary Outcomes
Headache frequency
Time Frame: Daily headache diary in three months.
The frequency of headaches is higher in the month before Ramadan compared to the month after ramadan.
Secondary Outcomes
No secondary outcomes reported
Investigators
Mohammad Al-Mahdi Al-Karagholi
MD
Danish Headache Center
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
MIBRAIN - Migraine and the Brain: Consequences, Causes, and Vascular InteractionMigraineNCT01803984University Hospital, Bordeaux166
Withdrawn
Phase 3
Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With ErenumabMigraineNCT04114630Novartis Pharmaceuticals
Unknown
Not Applicable
Rate , Predictors and Outcome of Chronic MigraineChronic Migraine, HeadacheChronic MigraineNCT05079659Assiut University296
Completed
Not Applicable
MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and ApplicationSelf-AssessmentMigraineNCT05979285Cumbria Partnership NHS Foundation Trust887
Completed
Not Applicable
An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult ParticipantsMigraineNCT05653986AbbVie391